These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
472 related articles for article (PubMed ID: 33738588)
81. Targeting autophagy in cancer stem cells as an anticancer therapy. Lei Y; Zhang D; Yu J; Dong H; Zhang J; Yang S Cancer Lett; 2017 May; 393():33-39. PubMed ID: 28216370 [TBL] [Abstract][Full Text] [Related]
82. Wnt/β‑catenin signaling: Causes and treatment targets of drug resistance in colorectal cancer (Review). Zhu GX; Gao D; Shao ZZ; Chen L; Ding WJ; Yu QF Mol Med Rep; 2021 Feb; 23(2):. PubMed ID: 33300082 [TBL] [Abstract][Full Text] [Related]
83. Clinical Implications of Colorectal Cancer Stem Cells in the Age of Single-Cell Omics and Targeted Therapies. Frank MH; Wilson BJ; Gold JS; Frank NY Gastroenterology; 2021 May; 160(6):1947-1960. PubMed ID: 33617889 [TBL] [Abstract][Full Text] [Related]
84. CD51 correlates with the TGF-beta pathway and is a functional marker for colorectal cancer stem cells. Wang J; Zhang B; Wu H; Cai J; Sui X; Wang Y; Li H; Qiu Y; Wang T; Chen Z; Zhu Q; Xia H; Song W; Xiang AP Oncogene; 2017 Mar; 36(10):1351-1363. PubMed ID: 27593923 [TBL] [Abstract][Full Text] [Related]
85. CD133+, CD166+CD44+, and CD24+CD44+ phenotypes fail to reliably identify cell populations with cancer stem cell functional features in established human colorectal cancer cell lines. Muraro MG; Mele V; Däster S; Han J; Heberer M; Cesare Spagnoli G; Iezzi G Stem Cells Transl Med; 2012 Aug; 1(8):592-603. PubMed ID: 23197865 [TBL] [Abstract][Full Text] [Related]
86. Cancer Stem Cell Niche in Colorectal Cancer and Targeted Therapies. Wang H; Cui G; Yu B; Sun M; Yang H Curr Pharm Des; 2020; 26(17):1979-1993. PubMed ID: 32268862 [TBL] [Abstract][Full Text] [Related]
87. Cancer stem cells in colorectal cancer: a review. Munro MJ; Wickremesekera SK; Peng L; Tan ST; Itinteang T J Clin Pathol; 2018 Feb; 71(2):110-116. PubMed ID: 28942428 [TBL] [Abstract][Full Text] [Related]
88. The Identifications and Clinical Implications of Cancer Stem Cells in Colorectal Cancer. Wahab SMR; Islam F; Gopalan V; Lam AK Clin Colorectal Cancer; 2017 Jun; 16(2):93-102. PubMed ID: 28237538 [TBL] [Abstract][Full Text] [Related]
89. MiR-24 induces chemotherapy resistance and hypoxic advantage in breast cancer. Roscigno G; Puoti I; Giordano I; Donnarumma E; Russo V; Affinito A; Adamo A; Quintavalle C; Todaro M; Vivanco MD; Condorelli G Oncotarget; 2017 Mar; 8(12):19507-19521. PubMed ID: 28061479 [TBL] [Abstract][Full Text] [Related]
90. Phosphosulindac (OXT-328) selectively targets breast cancer stem cells in vitro and in human breast cancer xenografts. Zhu C; Cheng KW; Ouyang N; Huang L; Sun Y; Constantinides P; Rigas B Stem Cells; 2012 Oct; 30(10):2065-75. PubMed ID: 22653497 [TBL] [Abstract][Full Text] [Related]
91. Combination Therapy of Lactobacillus plantarum Supernatant and 5-Fluouracil Increases Chemosensitivity in Colorectal Cancer Cells. An J; Ha EM J Microbiol Biotechnol; 2016 Aug; 26(8):1490-503. PubMed ID: 27221111 [TBL] [Abstract][Full Text] [Related]
92. Adenylate kinase hCINAP determines self-renewal of colorectal cancer stem cells by facilitating LDHA phosphorylation. Ji Y; Yang C; Tang Z; Yang Y; Tian Y; Yao H; Zhu X; Zhang Z; Ji J; Zheng X Nat Commun; 2017 May; 8():15308. PubMed ID: 28516914 [TBL] [Abstract][Full Text] [Related]
93. Cancer stem cells in human gastrointestinal cancer. Taniguchi H; Moriya C; Igarashi H; Saitoh A; Yamamoto H; Adachi Y; Imai K Cancer Sci; 2016 Nov; 107(11):1556-1562. PubMed ID: 27575869 [TBL] [Abstract][Full Text] [Related]
94. MicroRNAs are important regulators of drug resistance in colorectal cancer. Zhang Y; Wang J Biol Chem; 2017 Jul; 398(8):929-938. PubMed ID: 28095367 [TBL] [Abstract][Full Text] [Related]
95. Isolation and identification of chemotherapy-enriched sphere-forming cells from a patient with gastric cancer. Bagheri V; Memar B; Behzadi R; Aliakbarian M; Jangjoo A; Bahar MM; Talebi S; Gholamin M; Abbaszadegan MR J Cell Physiol; 2018 Oct; 233(10):7036-7046. PubMed ID: 29744869 [TBL] [Abstract][Full Text] [Related]
96. Role of Notch signaling in colon homeostasis and carcinogenesis. Miyamoto S; Rosenberg DW Cancer Sci; 2011 Nov; 102(11):1938-42. PubMed ID: 21801279 [TBL] [Abstract][Full Text] [Related]
97. Cancer stem cells in colorectal cancer: Signaling pathways involved in stemness and therapy resistance. Ebrahimi N; Afshinpour M; Fakhr SS; Kalkhoran PG; Shadman-Manesh V; Adelian S; Beiranvand S; Rezaei-Tazangi F; Khorram R; Hamblin MR; Aref AR Crit Rev Oncol Hematol; 2023 Feb; 182():103920. PubMed ID: 36702423 [TBL] [Abstract][Full Text] [Related]
98. Maintenance of cancer stemness by miR-196b-5p contributes to chemoresistance of colorectal cancer cells via activating STAT3 signaling pathway. Ren D; Lin B; Zhang X; Peng Y; Ye Z; Ma Y; Liang Y; Cao L; Li X; Li R; Sun L; Liu Q; Wu J; Zhou K; Zeng J Oncotarget; 2017 Jul; 8(30):49807-49823. PubMed ID: 28591704 [TBL] [Abstract][Full Text] [Related]
99. Therapeutic implications of an enriched cancer stem-like cell population in a human osteosarcoma cell line. Martins-Neves SR; Lopes ÁO; do Carmo A; Paiva AA; Simões PC; Abrunhosa AJ; Gomes CM BMC Cancer; 2012 Apr; 12():139. PubMed ID: 22475227 [TBL] [Abstract][Full Text] [Related]
100. Combination therapy with epigenetic-targeted and chemotherapeutic drugs delivered by nanoparticles to enhance the chemotherapy response and overcome resistance by breast cancer stem cells. Li SY; Sun R; Wang HX; Shen S; Liu Y; Du XJ; Zhu YH; Jun W J Control Release; 2015 May; 205():7-14. PubMed ID: 25445694 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]